Borghesani Valentina
Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy.
J Pept Sci. 2025 Jan;31(1):e3649. doi: 10.1002/psc.3649. Epub 2024 Aug 9.
Uronium peptide coupling agents (HBTU, HATU, and HCTU) create a special hazard as they are immune sensitizers. Few reported cases are mentioned in the literature; despite that, it is important to raise the awareness on the subject and to highlight the risk and potential symptoms that could occur to those who directly work in contact with uronium peptide coupling agents, as well as to the safety deputies in the universities and industries. Based on a personal experience, the health impact of laboratory exposure to HBTU is described, and the insights gained from the experience are developed. A skin irritation reaction and allergy symptoms induced by HBTU exposure are shown here as well as the rate of worsening of symptoms since the first allergic reaction. Recommendations for handling coupling agents more safely in the research laboratory will also be given, and a casuistry of the matter to help other lab-users to recognize, assess, minimize, prepare for emergencies (RAMP) process.
脲鎓肽偶联剂(HBTU、HATU和HCTU)具有特殊危害,因为它们是免疫致敏剂。文献中提及的病例较少;尽管如此,提高对该主题的认识并强调直接接触脲鎓肽偶联剂的工作人员以及大学和行业中的安全代表可能出现的风险和潜在症状非常重要。基于个人经历,描述了实验室接触HBTU对健康的影响,并阐述了从该经历中获得的见解。这里展示了HBTU暴露引起的皮肤刺激反应和过敏症状,以及自首次过敏反应以来症状的恶化程度。还将给出在研究实验室更安全地处理偶联剂的建议,以及该问题的案例分析,以帮助其他实验室使用者认识、评估、尽量减少风险并为紧急情况做好准备(RAMP)。